Skip to main content
KRMD logo

KORU Medical Systems, Inc. (KRMD) Stock: Price, Forecast & Analyst Target

KORU Medical Systems, Inc. (KRMD) — MoonshotScore 23/100 (Weak band), calculated Nov 18, 2026. Price $3.44 (-0.29%), as of the Nov 19, 2026 trading session; market cap $149M.

Educational signal · not a buy or sell recommendation · How to read this

$3.44 −$0.01 (-0.29%) Market Cap $149M

KORU Medical Systems, Inc. · KRMD · NASDAQ

KORU Medical Systems, Inc. specializes in the design and manufacture of portable medical devices for the ambulatory infusion market. The company aims to enhance patient care through innovative infusion solutions and educational resources.

Price as of Nov 19, 2026

Key Statistics

23 of 100

MoonshotScore v2 · KORU Medical Systems (KRMD)

Weak
Business Quality Solid (62)
Financial Safety Okay (57)
Valuation Fair (73)
Growth Durability Flat (59)
Momentum Rising (61)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

Middling on every pillar — nothing weak enough to single out, nothing strong enough to stand on. The score also carries a risk penalty for a bankruptcy-risk score in the distress zone and losses on top of negative retained earnings. Business Quality: Solid; Financial Safety: Okay; Valuation: Fair; Growth Durability: Flat; Momentum: Rising.

  • quarterly revenue $10M (Q3 FY2025, quarter ended Sep 2025)
  • EPS beat 1 of the last 3 reports
  • Altman Z -1.02 · Piotroski F 4

Helping: an attractive price

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for KRMD (58 recorded, newest six shown)
RecordedScoreBand
23Weak
23Weak
23Weak
23Weak
23Weak
23Weak

Daily score refresh is delayed. This is the last recorded calculation.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$3.44
Change on the day-0.29%
Market capitalisation$149M—
Price / earnings (trailing)0.00
Shares traded on the day203.7K

Price & events

Other perspectives

Council score for KORU Medical Systems (KRMD): perspectives

Some lenses disagree with the MoonshotScore. Compare their readings below; each uses a different method.

5-Factor Breakdown

Business Quality Moderate
Financial Safety Neutral
Valuation Moderate
Growth Durability Neutral
Momentum Moderate

Legends Council

4 lenses, 4 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Griffin-style lens (simulated) Ken Griffin Favorable read
Englander-style lens (simulated) Izzy Englander Favorable read
Klarman-style lens (simulated) Seth Klarman Unfavorable read
Moon AI lens (model) Neutral read

Read on: Nov 21, 2026

Munger's Mindset

Balance Sheet & Valuation

Financial Health Neutral
Margin of Safety Fairly Valued
Profit Margin Weak
Revenue Growth Strong
Debt/Equity Moderate
ROE Negative
Gross Margin Strong

Read on: Nov 20, 2026

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

Two of these lenses read this company more favourably than the MoonshotScore does: Griffin-style lens and Englander-style lens. Each lens is a separate scoring function over its own inputs, so a disagreement is a difference of method rather than a correction — the page's answer stays the MoonshotScore above.

The Munger lens reads the current price as fairly valued against its own estimate of value.

Readings on this page are from Nov 21, 2026, except a card that shows its own read date.

1 · What is it?

What is KORU Medical Systems (KRMD), and what does it report?

Short answer

A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. KORU Medical Systems, Inc. (KRMD) is listed on NASDAQ. It employs 73 people. In Q3 FY2025 it reported revenue of $10M and net income of -$777,966. The market values it at $149M.

2 · Latest results

What do the latest results show for KORU Medical Systems (KRMD)?

Short answer · as of

The most recent reported quarter, Q3 FY2025, carried revenue of $10M. Against analyst estimates the company has EPS beat 1 of the last 3 reports.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q3 FY2025$10M-$777,966-$0.02 (diluted)
Q4 FY2025$11M-$486,856—
Q1 FY2026$12M-$807,078-$0.02 (diluted)
Q2 FY2026$12M$252,449$0.01 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for KORU Medical Systems (KRMD)?

Short answer

The MoonshotScore pillars rate an attractive price as strengths. The distress and quality screens read Altman Z -1.02 · Piotroski F 4. Trailing ratios: ROE -4.6% · ROA -1.3% · current ratio 2.96.

Data-derived red flags

  • Financial-distress signal — its Altman Z-Score of -1.02 sits in the distress zone (elevated bankruptcy risk).
  • Negative return on equity (-4.6%) — the business is not currently generating profit on shareholder capital.
4 · What to check next?

What should you watch next at KORU Medical Systems (KRMD)?

Short answer · as of

Current published price targets run low $6.00 · high $6.00 · consensus $6.00 · median $6.00 against a quoted price of $3.44 (as of Nov 19, 2026).

What the records here don't tell us

  • No forward revenue or earnings estimate is on file.
  • The next earnings date is not yet scheduled in the calendar we read.
  • The newest quarter held here (Q3 FY2025) was filed Nov 12, 2025 — 12 months ago.

Checked against the records this page reads, on the dates shown above.

5 · Peer comparison

How does KORU Medical Systems compare with its peers?

Short answer

KORU Medical Systems's score ranks 13th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
Utah Medical Products, Inc. (UTMD) Same industry, near in market value$70.96 Nov 19, 2026$202M87 5-pillar Nov 18, 2026
Pro-Dex, Inc. (PDEX) Same industry, near in market value$63.49 Nov 19, 2026$203M87 5-pillar Nov 18, 2026
InfuSystem Holdings, Inc. (INFU) Same industry, near in market value$14.06 Nov 19, 2026$282M85 5-pillar Nov 18, 2026
Medtronic plc (MDT) Named competitor$100.61 Nov 19, 2026$129B81 5-pillar Nov 18, 2026
ArthroCare Corp. (ARTC) Same industry, near in market value$10.05 Nov 19, 2026$350M65 5-pillar Nov 18, 2026
Baxter International Inc. (BAX) Named competitor$25.39 Nov 19, 2026$13.1B57 5-pillar Nov 18, 2026
Anbio Biotechnology (NNNN) Same industry, near in market value$3.65 Nov 19, 2026$160M55 5-pillar Nov 18, 2026
Daxor Corporation (DXR) Same industry, near in market value$7.83 Nov 19, 2026$45.7M47 5-pillar Nov 18, 2026
Sanara MedTech Inc. (SMTI) Same industry, near in market value$32.67 Nov 19, 2026$300M39 5-pillar Nov 18, 2026
Precision Optics Corporation, Inc. (POCI) Same industry, near in market value$4.07 Nov 19, 2026$44.8M39 5-pillar Nov 18, 2026
AngioDynamics, Inc. (ANGO) Same industry, near in market value$10.76 Nov 19, 2026$453M37 5-pillar Nov 18, 2026
OraSure Technologies, Inc. (OSUR) Same industry, near in market value$3.61 Nov 19, 2026$249M35 5-pillar Nov 18, 2026
KORU Medical Systems (KRMD) — this page$3.44$149M23

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

The records behind this page

Analyst targets & estimates

What analysts have on file

Price target, low to high
$6.00 – $6.00
Consensus target
$6.00
Median target
$6.00

Consensus record · Captured .

Measured against a quoted price of $3.44 (as of Nov 19, 2026).

Insider activity

Form 4 records via FMP · Of the newest 100 records, those within the last 180 days, newest dated Oct 1, 2026

Transactions
19
Identified insiders
7
Purchases
3
Sales
0
Other transactions
16

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held KRMD in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported KRMD in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about KORU Medical Systems (KRMD)?

Read these with our analysis →

Investor Questions: KRMD Stock

These answers are editorial: 1 of these 9 answers is drawn from the KRMD research dossier (written May 10, 2026 by gpt-4o-mini); the other 8 are question templates that restate figures shown above. Figures in this section are not part of the source register.

What does the MoonshotScore mean for KRMD?

KRMD carries the MoonshotScore stated above — the Weak band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers. KORU Medical Systems, Inc. specializes in the design and manufacture of portable medical devices for the ambulatory infusion market.

Is KRMD a good stock to buy?

Stock Expert AI does not rate KRMD buy, sell or hold. KORU Medical Systems, Inc. carries a MoonshotScore, in the Weak band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.

What is the KRMD stock price today?

The last price recorded for KORU Medical Systems, Inc. (KRMD), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What is the KRMD price target?

The analyst consensus price target for KORU Medical Systems, Inc. (KRMD), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.

What does KORU Medical Systems, Inc. do?

KORU Medical Systems, Inc. designs and manufactures portable medical devices specifically for the ambulatory infusion market. Their product line includes the FREEDOM infusion systems, which are designed to enhance patient comfort and safety during infusion therapy.

What are the key factors to evaluate for KRMD?

KORU Medical Systems, Inc. (KRMD) holds a MoonshotScore in the low range. To weigh it, compare the trailing P/E under Price & valuation with the analyst view under Analyst targets & estimates on this page. Not financial advice.

How frequently does KRMD data refresh on this page?

KRMD's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.

What has driven KRMD's recent stock price performance?

KORU Medical Systems, Inc. (KRMD) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Innovative product line tailored for ambulatory infusion. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider KRMD overvalued or undervalued right now?

The trailing P/E of KORU Medical Systems, Inc. (KRMD) is listed under Price & valuation, and the analyst consensus target under Analyst targets & estimates, on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Machine-generated analysis by Stock Expert AI — model gpt-4o-mini, generated May 10, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 19 figures on this page — 15 from Financial Modeling Prep (FMP), 3 with no recorded source and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.